CLVSQ — Clovis Oncology Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.17m
- $604.23m
- $148.76m
Clovis Oncology Inc reports results for the quarter ended in March - Earnings Summary
Clovis Oncology: Falls on lower Q1 product revenue
Brief: Clovis Oncology Announces Q1 Loss Per Share Of $0.64
Clovis Oncology Inc expected to post a loss of 72 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Clovis, Tesla, Skillz
Clovis: Jumps on positive data for drug in ovarian cancer study
Brief: Clovis Oncology Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
U.S. RESEARCH ROUNDUP- Fortive, Intuit, Workday
Brief: Clovis Oncology Announces 2020 Operating Results
Brief: Clovis Oncology Announces Preliminary Product Revenues For Q4 And Full Year 2020
Brief: Clovis Oncology Submits Investigational New Drug Applications For Novel Peptide-Targeted Radionuclide Fap-2286 For Therapeutic And Imaging Clinical Trial
U.S. STOCKS ON THE MOVE-Tesla, Anterix Inc, Nike
Brief: Clovis Oncology's Rubraca Met The Primary Endpoint In Phase 3 Treatment Study In Later-Line Ovarian Cancer Patients With A Brca Mutation
Clovis Oncology: Up after ovarian cancer drug meets main goal in late-stage study
Brief: Clovis Oncology Files For Stock Shelf Offering By Selling Stockholders Of Up To $10.1 Million - SEC Filing
U.S. STOCKS ON THE MOVE- Albemarle, Barrick Gold, Qualcomm, Nikola, Canopy Growth
U.S. STOCKS ON THE MOVE-Qualcomm, Merck, cannabis cos, Electronic Arts
U.S. STOCKS ON THE MOVE-Pot stocks, Barrick Gold, General Motors, Qualcomm, Apple
Clovis Oncology falls on $50 mln debt offering